262% share price rise for Perth biotech after IPO

23/09/2019 - 12:35

Bookmark

Save articles for future reference.

Singapore and Perth-based biotech company Osteopore has begun life on the ASX today with a sharp share price surge, following a $5.25 million initial public offering.

To read our articles you will need to either login or subscribe.

STANDING BY BUSINESS. TRUSTED BY BUSINESS.

Subscription Options